European Union
November 13, 2026
A new report on plant biotechnology inventions provides the latest analysis of EPO practice, as well as filing, grant and caseload data, complemented by insights from discussions with key stakeholders. The report demonstrates how the EPO contributes to legal certainty in an area of crucial importance for global sustainability.
The latest status report from the European Patent Office (EPO) on its examination practice for plant-related inventions was presented to the Committee on Patent Law on 12 November 2026. This expert committee is part of the Administrative Council of the European Patent Organisation.
The report is the seventh of its kind since 2020 and provides comprehensive information on the EPO’s activities in the area of plant-related inventions, including statistics on the number of European patent applications and granted European patents, developments in the legal framework and progress made on examining pending cases. There are also insights gained from the EPO’s exchanges with various stakeholders.
Supporting evidence-based discussions
Innovation in plant breeding is promoted by both the European Union and the United Nations to foster a more resilient and sustainable agri-food system. The EPO has devoted particular attention to the sector for many years and hosts regular exchanges on the topic with representatives of its 40 member states.
In addition, the EPO is in regular discussions with numerous stakeholders throughout Europe and around the world, including the European Commission, the Community Plant Variety Office (CPVO), organisations representing breeders and farmers, as well as with NGOs. By sharing its expertise, the EPO fosters evidence-based discussions on how to balance innovation in plant breeding with transparency and access to breeding material.
Contributing to policy development and competitiveness
These initiatives are of increasing significance in view of recent policy developments, including the adoption of the EU Regulation on plants obtained by certain new genomic techniques (NGTs) and their products. This regulation foresees the establishment of an expert group – including representatives from the EPO and CPVO – to assess the impact of patent protection on NGT plants. The EPO also contributes to policy discussions about strengthening the EU’s competitiveness in biotechnology, as well as the urgent need to adapt agricultural systems to changing climate conditions.
Further information
EPO practice on plant- and animal-related inventions: status report (CA/PL 19/26)Committee on Patent Law of the Administrative CouncilPatentability for biotechnology and plants explainedPodcast on green biotech: growing resilience for tomorrow’s food security (16 September 2026)EPO Technology Dashboard 2026: Insight into plant biotechnologyEPO’s Guidelines for Examination, Part G-II, 5.4Directive 98/44/EC on the legal protection of the biotechnological inventionsEU Regulation on plants obtained by certain new genomic techniques and their products